Peak Resorts Announces New Line of Credit and Refinance of Certain Existing Credit Facilities
Aug 30, 2017 12:00 pm UTC| Business
New $10 Million Line of Credit to Provide Increased Operational FlexibilityAcquisition Line of Credit Renewed Total Debt Outstanding Remains Unchanged WILDWOOD, Mo., Aug. 30, 2017 -- Peak Resorts, Inc. (NASDAQ:SKIS),...
Qorvo® to Present at the Citi 2017 Global Technology Conference
Aug 30, 2017 12:00 pm UTC| Business
GREENSBORO, N.C., Aug. 30, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Citi 2017 Global...
Aug 30, 2017 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2017 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Motorcar Parts of America to Present at CL King’s 15th Annual Best Ideas Investor Conference
Aug 30, 2017 12:00 pm UTC| Business
LOS ANGELES, Aug. 30, 2017 -- Motorcar Parts of America, Inc. (Nasdaq:MPAA) today announced it is scheduled to make a presentation on Thursday, September 14, 2017 at the 15th Annual CL King Best Ideas Investor...
Aug 30, 2017 12:00 pm UTC| Business
BURLINGTON, Mass., Aug. 30, 2017 -- Nuance Communications, Inc. (NASDAQ:NUAN) today announced it was named market share leader for 2016 among global device and print management vendors by IDC, a leading IT market...
SecureAuth Continues to Raise the Bar on Passwordless Authentication with New Access Control Methods
Aug 30, 2017 12:00 pm UTC| Business
IRVINE, Calif., Aug. 30, 2017 -- SecureAuth® Corp., the pioneer in advanced adaptive access control for user authentication, is giving organizations the ability to ditch the password with new authentication methods that...
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
Aug 30, 2017 12:00 pm UTC| Business
CAMBRIDGE, Mass., Aug. 30, 2017 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...